Serial Venous Blood Sample Collection Before and Following Arteriovenous Fistula Creation or Arteriovenous Graft Placement.

Overview

About this study

The purpose of this study is to request collection of venous blood samples before arteriovenous graft/fistula creation and 28 days after the procedure.
Another separate purpose of this protocol is to save the venous blood vessel sample that is produced when the arteriovenous graft/fistula creation procedure takes place. These samples shall be used in future studies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All patients who will be undergoing AVF/AVG placement upon consent.

Exclusion Criteria:

  • Unwillingness/unable to provide informed consent.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/01/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sanjay Misra, M.D.

Contact us for the latest status

Contact information:

Jennifer Murphy

(507) 538-0540

Murphy.Jennifer@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20577455

Mayo Clinic Footer